Pharmacokinetics and Pharmacodynamics of Anti-BR3 Monoclonal Antibody in Mice

2012 
Purpose To characterize the pharmacokinetic (PK) and pharmacodynamic (PD) properties of a monoclonal antibody directed against the B-cell activating factor (BAFF) receptor 3 (BR3), following intravenous (IV) and subcutaneous (SC) administration in mice.
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    31
    References
    1
    Citations
    NaN
    KQI
    []